119-S832

Bill is currently in: Senate
Path to Law
House Senate President

119th CONGRESS

1st Session

S. 832

1. Short title
2. Equalizing the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program

1. Short title

This Act may be cited as the "Ensuring Pathways to Innovative Cures Act of 2025" or the "EPIC Act of 2025".

2. Equalizing the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program

Section 1192(e)(1)(A)(ii) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)(A)(ii)) is amended—

(1) - by striking "year, at least 7" and inserting “year—

(I) - for initial price applicability years 2026 and 2027, at least 7

(2) - by adding at the end the following:

(II) - for initial price applicability year 2028 and each subsequent initial price applicability year, at least 11 years will have elapsed since the date of such approval; and